| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/147.1.116 |
| P698 | PubMed publication ID | 6822746 |
| P2093 | author name string | Smith JW | |
| Luby JP | |||
| Cooper BH | |||
| Mackowiak PA | |||
| Seidenfeld SM | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida parapsilosis | Q144068 |
| amphotericin B | Q412223 | ||
| P304 | page(s) | 116-119 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. | |
| P478 | volume | 147 |
| Q43664354 | Antifungal susceptibility of emerging yeast pathogens |
| Q33975757 | Antifungal susceptibility testing: practical aspects and current challenges |
| Q37450019 | Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis |
| Q37613000 | Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility |
| Q91983100 | Candida parapsilosis: from Genes to the Bedside |
| Q38229535 | Candidiasis |
| Q35588495 | Central nervous system candidiasis in the high-risk neonate |
| Q49204068 | Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species |
| Q28379470 | Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis |
| Q43578712 | Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections |
| Q50353513 | Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing. |
| Q40174128 | Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin |
| Q72895880 | Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party |
| Q44380989 | Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species |
| Q30452880 | New and emerging yeast pathogens |
| Q77372912 | Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis |
| Q40968227 | Patterns of amphotericin B killing kinetics against seven Candida species. |
| Q64070466 | Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B |
| Q40531623 | Resistance to antifungal agents |
| Q58815576 | Secular Trends in the Epidemiology of Nosocomial Fungal Infections at a Teaching Hospital in Taiwan, 1981 to 1993 |
| Q40774513 | Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation. |
| Q46290886 | Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015. |
| Q80264665 | Systemic antifungal agents |
| Q37186512 | Trichosporon beigelii, an emerging pathogen resistant to amphotericin B |
| Q40722965 | What's new in fungal infection in leukemic patients |
Search more.